Theravance Biopharma, Inc. (TBPH)
USD 8.77
(-2.66%)
USD 8.77
(-2.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 57.42 Million | 51.34 Million | 55.31 Million | 71.85 Million | 73.41 Million | 60.37 Million |
| Cost of Revenue | 40.62 Million | 6.58 Million | 7.28 Million | 260.95 Million | 219.24 Million | 715 Thousand |
| Gross Profit | 16.8 Million | 44.75 Million | 48.02 Million | -189.09 Million | -145.83 Million | 59.65 Million |
| Operating Expenses | 110.71 Million | 130.46 Million | 292.95 Million | 369.61 Million | 325.32 Million | 298.4 Million |
| Selling, General and Administrative Expenses | 70.09 Million | 67.07 Million | 99.29 Million | 108.66 Million | 106.08 Million | 97.05 Million |
| Research and Development Expenses | 40.62 Million | 63.39 Million | 193.65 Million | 260.95 Million | 219.24 Million | 201.34 Million |
| Other Expenses | - | - | - | -1.61 Million | - | - |
| Cost and Expenses | 110.71 Million | 130.46 Million | 292.95 Million | 369.61 Million | 325.32 Million | 299.12 Million |
| Operating Income | -53.29 Million | -91.95 Million | -257.78 Million | -297.75 Million | -251.91 Million | -238.75 Million |
| Interest Expense | 2.35 Million | 6.36 Million | 46.88 Million | 44.58 Million | 31.86 Million | 10.48 Million |
| Income Tax Expense | 5.92 Million | 9000.00 | -151 Thousand | -8.52 Million | -5.22 Million | -10.56 Million |
| Earnings before Tax | -49.26 Million | -92.81 Million | -199.57 Million | -286.53 Million | -241.67 Million | -226.08 Million |
| Net Income | -55.19 Million | -92.82 Million | -199.42 Million | -278.01 Million | -236.45 Million | -215.52 Million |
| Earnings Per Share Basic | -1.00 | -1.26 | -2.87 | -4.46 | -4.25 | -3.99 |
| Earnings Per Share Diluted | -1.00 | -1.26 | -2.87 | -4.46 | -4.25 | -3.99 |
| Weighted Average Shares Outstanding | 55.3 Million | 73.59 Million | 69.46 Million | 62.34 Million | 55.61 Million | 53.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.3 Million | 73.59 Million | 69.46 Million | 62.34 Million | 55.61 Million | 53.96 Million |
| Gross Margin | 0.29 | 0.87 | 0.87 | -2.63 | -1.99 | 0.99 |
| EBIT Margin | -0.71 | -1.37 | -2.40 | -3.15 | -2.86 | -3.57 |
| Profit Margin | -0.96 | -1.81 | -3.61 | -3.87 | -3.22 | -3.57 |
| EBITDA | -40.86 Million | -79.85 Million | -249.38 Million | -293.99 Million | -203.29 Million | -212.43 Million |
| Earnings Before Tax Margin | -0.93 | -1.79 | -4.66 | -4.14 | -3.43 | -3.95 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.25 Million | 14.5 Million | 57.42 Million | 17.56 Million | 15.69 Million | 13.74 Million |
| Cost of Revenue | 1.55 Million | 1.53 Million | 6.05 Million | 4.33 Million | 1.33 Million | 1.33 Million |
| Gross Profit | 12.69 Million | 12.97 Million | 51.37 Million | 13.23 Million | 14.35 Million | 12.41 Million |
| Operating Expenses | 25.45 Million | 24.17 Million | 110.71 Million | 23.8 Million | 24.45 Million | 28.7 Million |
| Selling, General and Administrative Expenses | 15.92 Million | 15.64 Million | - | 15.49 Million | 16.14 Million | 19.27 Million |
| Research and Development Expenses | 9.52 Million | 8.53 Million | - | 8.31 Million | 8.31 Million | 9.42 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 27.01 Million | 25.71 Million | 110.71 Million | 23.8 Million | 24.45 Million | 28.7 Million |
| Operating Income | -12.75 Million | -11.2 Million | -53.29 Million | -6.24 Million | -8.76 Million | -16.12 Million |
| Interest Expense | 644 Thousand | -629 Thousand | 2.35 Million | 623 Thousand | 609 Thousand | 568 Thousand |
| Income Tax Expense | 1.3 Million | 1.26 Million | 5.92 Million | 3.49 Million | 1.36 Million | 1.45 Million |
| Earnings before Tax | -15.22 Million | -10.4 Million | -49.26 Million | -5.01 Million | -7.58 Million | -14.18 Million |
| Net Income | -16.52 Million | -11.66 Million | -55.19 Million | -8.51 Million | -8.95 Million | -15.64 Million |
| Earnings Per Share Basic | -0.34 | -0.24 | - | -0.17 | -0.17 | -0.28 |
| Earnings Per Share Diluted | -0.34 | -0.24 | - | -0.17 | -0.17 | -0.28 |
| Weighted Average Shares Outstanding | 48.74 Million | 48.28 Million | 55.3 Million | 49.41 Million | 52.36 Million | 56.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.74 Million | 48.28 Million | 55.3 Million | 49.41 Million | 52.36 Million | 56.68 Million |
| Gross Margin | 0.89 | 0.89 | 0.89 | 0.75 | 0.91 | 0.90 |
| EBIT Margin | -0.79 | -0.67 | - | -0.19 | -0.44 | -0.91 |
| Profit Margin | -1.16 | -0.80 | -0.96 | -0.48 | -0.57 | -1.14 |
| EBITDA | -11.19 Million | -9.67 Million | - | -3.33 Million | -6.97 Million | -12.45 Million |
| Earnings Before Tax Margin | -0.89 | -0.77 | -0.93 | -0.36 | -0.56 | -1.17 |
1373
KCO
ONFOW
DSKY
ROU
UPR